AbbVie Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Quarter	Current	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021
Period Ending	Jul '26 Jul 21, 2026	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Sep '25 Sep 30, 2025	Jun '25 Jun 30, 2025	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Sep '24 Sep 30, 2024	Jun '24 Jun 30, 2024	Mar '24 Mar 31, 2024	Dec '23 Dec 31, 2023	Sep '23 Sep 30, 2023	Jun '23 Jun 30, 2023	Mar '23 Mar 31, 2023	Dec '22 Dec 31, 2022	Sep '22 Sep 30, 2022	Jun '22 Jun 30, 2022	Mar '22 Mar 31, 2022	Dec '21 Dec 31, 2021	Sep '21 Sep 30, 2021
Market Cap	452,476	384,305	403,970	409,212	327,805	370,073	313,686	348,968	302,895	321,538	273,668	263,163	237,771	281,124	285,917	237,338	270,791	286,428	239,433	190,693
Market Cap Growth	38.03%	3.85%	28.78%	17.26%	8.22%	15.10%	14.62%	32.61%	27.39%	14.38%	-4.28%	10.88%	-12.19%	-1.85%	19.41%	24.46%	36.05%	49.90%	26.59%	23.33%
Enterprise Value	514,283	447,816	466,251	472,327	391,864	434,828	375,314	412,801	360,415	377,510	320,274	310,654	290,052	336,524	339,992	295,098	333,797	352,361	306,315	259,192
Last Close Price	256.10	217.49	228.49	231.54	185.62	209.52	177.70	197.48	171.52	182.10	154.97	149.06	134.73	159.37	161.61	134.21	153.16	162.11	135.40	107.87
PE Ratio	124.81	107.14	96.82	175.41	88.39	89.16	74.35	68.57	57.17	54.04	56.97	40.84	27.72	37.68	24.38	17.92	21.69	23.26	20.99	25.68
Forward PE	17.09	14.96	16.57	17.53	16.52	17.06	14.81	16.93	14.70	16.26	13.96	13.59	12.15	14.30	12.72	9.96	10.88	11.43	10.04	8.24
PEG Ratio	1.34	0.83	1.09	1.17	1.28	1.27	1.68	1.92	1.86	2.21	58.43	12.71	16.26	7.71	93.44	15.63	5.63	9.40	2.03	1.98
PS Ratio	7.18	6.12	6.61	6.86	5.62	6.45	5.57	6.28	5.51	5.91	5.04	4.77	4.24	4.95	4.93	4.10	4.72	5.05	4.26	3.46
PB Ratio	-	-57.74	-123.54	-154.89	-1791.28	260.62	94.34	57.85	44.69	40.16	26.42	21.76	18.48	21.18	16.57	14.84	18.48	17.59	15.54	14.07
P/FCF Ratio	22.56	19.23	22.67	20.79	17.97	24.05	17.59	22.34	17.04	14.69	12.40	10.64	9.59	11.95	11.79	10.83	12.19	12.99	10.89	8.80
P/OCF Ratio	21.24	18.11	21.23	19.62	17.00	22.56	16.68	21.14	16.25	14.17	11.98	10.31	9.31	11.60	11.46	10.51	11.81	12.56	10.51	8.45
EV/Sales Ratio	8.19	7.13	7.62	7.92	6.72	7.58	6.66	7.43	6.55	6.94	5.90	5.63	5.18	5.93	5.86	5.10	5.82	6.21	5.45	4.70
EV/EBITDA Ratio	17.19	19.16	20.08	27.31	20.37	23.60	21.42	18.61	17.34	17.61	14.93	13.03	11.10	13.62	12.79	11.36	13.04	13.10	11.58	10.28
EV/EBIT Ratio	23.51	29.21	30.93	52.24	35.73	43.17	41.08	29.87	29.37	29.52	25.11	20.62	16.68	20.81	18.77	16.68	19.19	19.01	17.09	15.61
EV/FCF Ratio	25.74	22.41	26.17	24.00	21.48	28.26	21.05	26.42	20.27	17.25	14.52	12.56	11.70	14.31	14.02	13.46	15.03	15.98	13.93	11.96
Debt / Equity Ratio	-9.76	-9.76	-19.03	-25.69	-496.49	45.23	17.94	9.64	8.51	7.93	5.02	4.59	4.33	4.46	3.42	3.77	4.15	3.89	4.16	5.46
Debt / EBITDA Ratio	3.12	12.30	10.34	17.33	10.15	12.11	109.71	12.03	11.53	15.19	11.27	13.45	9.01	12.69	8.26	10.22	13.64	10.85	10.87	12.55
Debt / FCF Ratio	3.65	20.44	13.81	10.35	14.43	49.92	9.94	13.67	34.80	19.24	13.06	8.26	9.94	15.45	8.77	9.38	15.00	15.48	15.69	10.46
Net Debt / Equity Ratio	-9.53	-9.53	-19.03	-23.87	-349.80	45.57	18.52	10.58	8.48	6.99	4.50	3.92	4.06	4.17	3.13	3.61	4.30	4.05	4.34	5.05
Net Debt / EBITDA Ratio	2.72	10.71	9.53	15.90	9.22	11.21	100.64	10.79	9.38	11.48	8.84	10.51	7.71	11.31	7.06	8.48	11.78	9.73	9.48	10.64
Net Debt / FCF Ratio	3.18	17.81	12.73	9.49	13.11	46.22	9.12	12.27	28.31	14.54	10.24	6.45	8.51	13.78	7.49	7.78	12.95	13.89	13.68	8.87
Asset Turnover	0.11	0.11	0.12	0.11	0.11	0.09	0.11	0.10	0.10	0.09	0.10	0.10	0.10	0.09	0.11	0.10	0.10	0.09	0.10	0.10
Inventory Turnover	3.68	0.88	1.00	1.13	0.95	0.91	1.06	1.00	1.02	1.01	1.49	1.81	1.14	1.09	1.24	1.60	1.23	1.20	1.34	1.34
Quick Ratio	0.52	0.52	0.41	0.47	0.48	0.48	0.43	0.44	0.59	0.72	0.63	0.71	0.63	0.66	0.69	0.69	0.61	0.56	0.56	0.75
Current Ratio	0.80	0.80	0.67	0.72	0.74	0.76	0.66	0.65	0.81	0.94	0.87	0.96	0.89	0.96	0.96	0.93	0.84	0.82	0.79	1.01
Return on Equity (ROE)	-27.07%	-27.07%	2669.12%	10.83%	28.16%	27.11%	-0.33%	17.19%	13.93%	12.85%	5.95%	12.65%	14.70%	1.63%	15.11%	26.70%	6.80%	29.91%	28.35%	22.03%
Return on Assets (ROA)	1.96%	1.96%	2.30%	0.36%	2.12%	2.03%	-0.01%	2.06%	1.84%	1.54%	1.59%	1.50%	2.52%	1.01%	3.22%	2.85%	1.78%	2.93%	3.24%	2.49%
Return on Invested Capital (ROIC)	2.89%	2.89%	3.34%	0.52%	3.62%	4.42%	-0.02%	4.29%	3.99%	3.62%	3.73%	3.33%	5.24%	2.01%	6.32%	5.46%	3.23%	5.23%	5.85%	4.42%
Return on Capital Employed (ROCE)	4.11%	4.11%	4.86%	1.95%	4.96%	3.60%	-1.54%	3.80%	3.94%	2.61%	3.10%	2.17%	4.26%	2.54%	4.99%	4.02%	2.89%	4.12%	4.35%	3.50%
Earnings Yield	0.80%	0.93%	1.03%	0.57%	1.13%	1.12%	1.34%	1.46%	1.75%	1.85%	1.76%	2.45%	3.61%	2.65%	4.10%	5.58%	4.61%	4.30%	4.76%	3.89%
FCF Yield	4.43%	5.20%	4.41%	4.81%	5.56%	4.16%	5.68%	4.48%	5.87%	6.81%	8.06%	9.40%	10.43%	8.37%	8.48%	9.24%	8.20%	7.70%	9.18%	11.37%
Dividend Yield	2.70%	0.80%	0.72%	0.71%	0.89%	0.79%	0.88%	0.79%	0.91%	0.86%	0.96%	1.00%	1.10%	0.94%	0.87%	1.05%	0.92%	0.88%	0.96%	1.21%
Payout Ratio	336.44%	444.03%	160.30%	1565.05%	310.24%	227.45%	-12509.10%	176.23%	200.73%	202.48%	319.47%	147.75%	129.69%	1113.39%	101.33%	63.41%	271.32%	56.26%	57.22%	72.82%
Buyback Yield / Dilution	-0.04%	-0.11%	-0.28%	0.00%	0.00%	0.06%	0.17%	-0.06%	0.00%	0.17%	0.34%	0.28%	0.28%	0.11%	0.00%	0.06%	0.00%	-0.17%	-0.11%	-0.17%
Total Shareholder Return	2.66%	0.69%	0.44%	0.71%	0.89%	0.85%	1.04%	0.73%	0.91%	1.03%	1.29%	1.28%	1.38%	1.06%	0.87%	1.11%	0.92%	0.71%	0.85%	1.04%

SEC Filings: 10-K · 10-Q